The diploma thesis contains the study for increase of the production effectiveness via improvement of Overall Equipment Effectiveness. It contains technical description, process description of the change and its financial evaluation. The thesis focuses on specification of the term Overall Equipment Effectiveness and its clarification for use in production company producing electronic devices. It contains real company example.

Purpose To assess radiography faculty perceptions of the effectiveness of online courses. Methods An original survey instrument was created by selecting items from 3 instruments used in prior research and adding unique questions designed to elicit demographic data from faculty. The sample included a national dataset of radiography faculty members employed in Joint Review Committee on Education in Radiologic Technology–accredited programs in the United States. Results Findings showed that faculty perceptions of online course effectiveness are not affected significantly by faculty position, type of institution, faculty age, or years of teaching experience. Positive perceptions of the effectiveness of online courses moderately increased with years of teaching online courses, number of online courses taught in the past 5 years, and perceived competence with the use of technology. Faculty satisfaction with interaction in online courses moderately increased as the years of teaching online courses increased. However, the number of years of teaching online courses was not related to faculty satisfaction with teaching online courses or faculty satisfaction with institutional support. Online technology acceptance had a moderately positive relationship with perceived ease of use and a strong positive relationship with perceived usefulness of online technology. In addition, the use of technology-enhanced learning methods had a strong positive relationship with technological self-efficacy. Conclusion Radiography faculty perceptions of the effectiveness of online courses improved with experience in teaching online courses and competence with use of technology. Perceived ease of use and perceived usefulness of online technology were related directly to online technology acceptance. Furthermore, faculty members with technological self-efficacy were more likely to use technology-enhanced learning methods in the online environment.

Objetivo: Comparar as relações de custo-efetividade de duas terapias, Imunoglubulina Intravenosa (IgIV) e Plasmaferese (PE), no tratamento da Síndrome de Guillain-Barré sob a perspectiva do sistema público (SUS). O objetivo secundário foi avaliar a adesão às recomendações da Comissão de Medicamentos do HCPA Métodos: estudo transversal com análise econômica de pacientes tratados por Síndrome de Guillain-Barré no período de junho de 2003 a junho de 2008 no Hospital de Clínicas de Porto Alegre (HCPA). Foi realizada análise de custo-efetividade do emprego de IgIV e de PE nestes pacientes, pelo método de minimização de custos, considerando-se somente os custos diretos sanitários, fornecidos pelo sistema gerencial da instituição . Foram excluídos os pacientes que usaram outro tipo de tratamento associado ou isolado. Coletaram-se os dados através da revisão dos prontuários. A gravidade da doença na internação foi classificada como: doença leve, quando caminhar foi possível; doença moderada, quando caminhar foi impossível; doença grave, quando os pacientes necessitaram de ventilação assistida. A incapacidade na alta foi estabelecida pela escala de sete pontos de Hughes. A adesão às recomendações da Comissão de Medicamentos do HCPA, objetivo secundário, foi avaliada através da dose e o esquema de prescrição da IgIV. Resultados: Vinte e cinco participantes (2 a 70 anos) foram incluídos no estudo, cinco tratados com PE, empregando-se Albumina Humana como substituto do plasma, e 20 tratados com IgIV. O custo total do tratamento de um paciente com PE foi R$10.603,88 (± 2.978,12) e o de um que recebeu IgIV foi R$ 32.103,00 (± 21.454,24). O custo total da internação foi de R$45.027,14 (± 32.750,45) para os tratados com PE e de R$ 60.844,28 (±48.590,52) para os que receberam IgIV. Em relação ao desfecho clínico principal, melhora na escala de incapacidade de sete pontos, após o tratamento com uma das alternativas escolhida, a mediana dos pacientes que internaram com grau de gravidade 3 e que foram tratados com PE foi igual a dos que receberam IgIV. Em relação à permanência hospitalar, permanência em UTI e dias de Ventilação Mecânica, não houve diferença estatisticamente significativa entre os dois tratamentos. Conclusões: Quando comparados os custos médios das duas opções terapêuticas, uma delas aparece claramente com menor custo. Quando comparados os desfechos, após o emprego de cada opção terapêutica, estes não revelam diferença. Concluímos que, no HCPA, a opção pelo procedimento Plasmaferese é mais custo efetiva do que o emprego da IgIV. / Objectives: To compare the cost-effectiveness of two distinct therapies, Intravenous Immunoglobulin (IVIg) and Plasma Exchange (PE) in the treatment of Guillain-Barré Syndrome, concerning the public health care system. Compliance to the guidelines of the Pharmacy and Therapeutics Committee of the Hospital de Clínicas de Porto Alegre was a secondary objective. Methods: A cross-sectional, economical analysis was conducted, including patients treated for GBS in the period from June, 2003 through June, 2008 in Hospital de Clínicas de Porto Alegre (HCPA). The cost-effectiveness of the use of IVIg and PE in such patients was studied through the cost minimization method, considering direct medical costs only (2008 currency), yield by the management of the institution. Patients receiving treatments other than PE or IVIg were excluded. Data were collected by chart reviews. Severity of disease on admittance was classified as follows: mild disease, when the patient was able to walk; moderate disease, when the patient was unable to walk, and severe disease, when assisted ventilation was required. Disability on discharge was established by the 7-point scale of Hughes. Compliance to the guidelines of the Pharmacy and Therapeutics Committee was evaluated through the dose and prescription scheme of IVIg. Results: Twenty-five participants (2 to 70 years of age) were included in the study, 5 were submitted to treatment with PE, using human albumin as replacement for plasma, and 20 were treated with IVIg. The total treatment cost for PE in a single patient was US$6,058.85 (±1,701.78 SD), and the same expense for IVIg was US$18,344.57 (± 12,259.56 SD) (p = 0.035). Total inpatient cost was US$25,729.79 (± 18,714.54 SD) in the PE group, and US$34,768.16 (±27,766.01 SD) (p=0.530) in the IVIg group. The main clinical outcome was improvement in the 7-point disability grade scale. The median of that measure in patients admitted with a severity grade 3 treated either with PE and IVIg was the same. Secondary outcomes, such as in-hospital stay, ICU stay, and number of days on mechanical ventilation revealed no statistically significant difference between treatments. Conclusions: As the mean expenses of both therapeutic options are compared, one clearly stands-out as less onerous. Clinical outcomes, when compared, reveal no statistical difference after each treatment. We concluded that, in HCPA, plasma exchange is more cost-effective than intravenous immunoglobulin.

<p>Design of products permits to yield goods and services to produce satisfaction on customers, which is measured as value. However, it is at this stage in which most of the environmental impact, from a lifecycle perspective, is added to the product. Eco-design aims at increasing value of products while reducing the burdens on the environment by means conscious design towards efficient use of resources. That efficiency, referred to as eco-efficiency, can be increased in a number of manners within environmental engineering. Traditionally, different fields have tackled materials, energy flows and products from different angles or approaches. In this thesis we describe Functional Sales (FS) and Industrial Ecology (IE) as examples of these. Within this latter, we put emphasis on Industrial Symbiosis (IS) and Eco-effectiveness. We consider these approaches are suitable to work in the framework of eco-design to increase ecoefficiency. By adding services to material products, and managing material and energy flows with a more ecological consciousness, we expect to increase value of products while reducing the impact on the environment.</p><p>To analyse this potential improvement, we developed a method involving a new eco-efficiency index (VERI), that recursively intends to ease decisions on possible eco-efficient alternatives. This index and its method are applied to a case study on management of olive oil supply in region of Murcia, Spain. Here, we propose three scenarios that will involve the implementation of FS and IE to compare the outcomes in value and environmental performance against an idealised current supply chain. The results obtained, although not accurate, suggest that FS and EI should be more taken into account in eco-design and, this latter, to also consider holistic viewpoints to find more eco-efficient alternatives for a product development.</p>

Design of products permits to yield goods and services to produce satisfaction on customers, which is measured as value. However, it is at this stage in which most of the environmental impact, from a lifecycle perspective, is added to the product. Eco-design aims at increasing value of products while reducing the burdens on the environment by means conscious design towards efficient use of resources. That efficiency, referred to as eco-efficiency, can be increased in a number of manners within environmental engineering. Traditionally, different fields have tackled materials, energy flows and products from different angles or approaches. In this thesis we describe Functional Sales (FS) and Industrial Ecology (IE) as examples of these. Within this latter, we put emphasis on Industrial Symbiosis (IS) and Eco-effectiveness. We consider these approaches are suitable to work in the framework of eco-design to increase ecoefficiency. By adding services to material products, and managing material and energy flows with a more ecological consciousness, we expect to increase value of products while reducing the impact on the environment. To analyse this potential improvement, we developed a method involving a new eco-efficiency index (VERI), that recursively intends to ease decisions on possible eco-efficient alternatives. This index and its method are applied to a case study on management of olive oil supply in region of Murcia, Spain. Here, we propose three scenarios that will involve the implementation of FS and IE to compare the outcomes in value and environmental performance against an idealised current supply chain. The results obtained, although not accurate, suggest that FS and EI should be more taken into account in eco-design and, this latter, to also consider holistic viewpoints to find more eco-efficient alternatives for a product development.

Objetivo: Comparar as relações de custo-efetividade de duas terapias, Imunoglubulina Intravenosa (IgIV) e Plasmaferese (PE), no tratamento da Síndrome de Guillain-Barré sob a perspectiva do sistema público (SUS). O objetivo secundário foi avaliar a adesão às recomendações da Comissão de Medicamentos do HCPA Métodos: estudo transversal com análise econômica de pacientes tratados por Síndrome de Guillain-Barré no período de junho de 2003 a junho de 2008 no Hospital de Clínicas de Porto Alegre (HCPA). Foi realizada análise de custo-efetividade do emprego de IgIV e de PE nestes pacientes, pelo método de minimização de custos, considerando-se somente os custos diretos sanitários, fornecidos pelo sistema gerencial da instituição . Foram excluídos os pacientes que usaram outro tipo de tratamento associado ou isolado. Coletaram-se os dados através da revisão dos prontuários. A gravidade da doença na internação foi classificada como: doença leve, quando caminhar foi possível; doença moderada, quando caminhar foi impossível; doença grave, quando os pacientes necessitaram de ventilação assistida. A incapacidade na alta foi estabelecida pela escala de sete pontos de Hughes. A adesão às recomendações da Comissão de Medicamentos do HCPA, objetivo secundário, foi avaliada através da dose e o esquema de prescrição da IgIV. Resultados: Vinte e cinco participantes (2 a 70 anos) foram incluídos no estudo, cinco tratados com PE, empregando-se Albumina Humana como substituto do plasma, e 20 tratados com IgIV. O custo total do tratamento de um paciente com PE foi R$10.603,88 (± 2.978,12) e o de um que recebeu IgIV foi R$ 32.103,00 (± 21.454,24). O custo total da internação foi de R$45.027,14 (± 32.750,45) para os tratados com PE e de R$ 60.844,28 (±48.590,52) para os que receberam IgIV. Em relação ao desfecho clínico principal, melhora na escala de incapacidade de sete pontos, após o tratamento com uma das alternativas escolhida, a mediana dos pacientes que internaram com grau de gravidade 3 e que foram tratados com PE foi igual a dos que receberam IgIV. Em relação à permanência hospitalar, permanência em UTI e dias de Ventilação Mecânica, não houve diferença estatisticamente significativa entre os dois tratamentos. Conclusões: Quando comparados os custos médios das duas opções terapêuticas, uma delas aparece claramente com menor custo. Quando comparados os desfechos, após o emprego de cada opção terapêutica, estes não revelam diferença. Concluímos que, no HCPA, a opção pelo procedimento Plasmaferese é mais custo efetiva do que o emprego da IgIV. / Objectives: To compare the cost-effectiveness of two distinct therapies, Intravenous Immunoglobulin (IVIg) and Plasma Exchange (PE) in the treatment of Guillain-Barré Syndrome, concerning the public health care system. Compliance to the guidelines of the Pharmacy and Therapeutics Committee of the Hospital de Clínicas de Porto Alegre was a secondary objective. Methods: A cross-sectional, economical analysis was conducted, including patients treated for GBS in the period from June, 2003 through June, 2008 in Hospital de Clínicas de Porto Alegre (HCPA). The cost-effectiveness of the use of IVIg and PE in such patients was studied through the cost minimization method, considering direct medical costs only (2008 currency), yield by the management of the institution. Patients receiving treatments other than PE or IVIg were excluded. Data were collected by chart reviews. Severity of disease on admittance was classified as follows: mild disease, when the patient was able to walk; moderate disease, when the patient was unable to walk, and severe disease, when assisted ventilation was required. Disability on discharge was established by the 7-point scale of Hughes. Compliance to the guidelines of the Pharmacy and Therapeutics Committee was evaluated through the dose and prescription scheme of IVIg. Results: Twenty-five participants (2 to 70 years of age) were included in the study, 5 were submitted to treatment with PE, using human albumin as replacement for plasma, and 20 were treated with IVIg. The total treatment cost for PE in a single patient was US$6,058.85 (±1,701.78 SD), and the same expense for IVIg was US$18,344.57 (± 12,259.56 SD) (p = 0.035). Total inpatient cost was US$25,729.79 (± 18,714.54 SD) in the PE group, and US$34,768.16 (±27,766.01 SD) (p=0.530) in the IVIg group. The main clinical outcome was improvement in the 7-point disability grade scale. The median of that measure in patients admitted with a severity grade 3 treated either with PE and IVIg was the same. Secondary outcomes, such as in-hospital stay, ICU stay, and number of days on mechanical ventilation revealed no statistically significant difference between treatments. Conclusions: As the mean expenses of both therapeutic options are compared, one clearly stands-out as less onerous. Clinical outcomes, when compared, reveal no statistical difference after each treatment. We concluded that, in HCPA, plasma exchange is more cost-effective than intravenous immunoglobulin.

Objetivo: Comparar as relações de custo-efetividade de duas terapias, Imunoglubulina Intravenosa (IgIV) e Plasmaferese (PE), no tratamento da Síndrome de Guillain-Barré sob a perspectiva do sistema público (SUS). O objetivo secundário foi avaliar a adesão às recomendações da Comissão de Medicamentos do HCPA Métodos: estudo transversal com análise econômica de pacientes tratados por Síndrome de Guillain-Barré no período de junho de 2003 a junho de 2008 no Hospital de Clínicas de Porto Alegre (HCPA). Foi realizada análise de custo-efetividade do emprego de IgIV e de PE nestes pacientes, pelo método de minimização de custos, considerando-se somente os custos diretos sanitários, fornecidos pelo sistema gerencial da instituição . Foram excluídos os pacientes que usaram outro tipo de tratamento associado ou isolado. Coletaram-se os dados através da revisão dos prontuários. A gravidade da doença na internação foi classificada como: doença leve, quando caminhar foi possível; doença moderada, quando caminhar foi impossível; doença grave, quando os pacientes necessitaram de ventilação assistida. A incapacidade na alta foi estabelecida pela escala de sete pontos de Hughes. A adesão às recomendações da Comissão de Medicamentos do HCPA, objetivo secundário, foi avaliada através da dose e o esquema de prescrição da IgIV. Resultados: Vinte e cinco participantes (2 a 70 anos) foram incluídos no estudo, cinco tratados com PE, empregando-se Albumina Humana como substituto do plasma, e 20 tratados com IgIV. O custo total do tratamento de um paciente com PE foi R$10.603,88 (± 2.978,12) e o de um que recebeu IgIV foi R$ 32.103,00 (± 21.454,24). O custo total da internação foi de R$45.027,14 (± 32.750,45) para os tratados com PE e de R$ 60.844,28 (±48.590,52) para os que receberam IgIV. Em relação ao desfecho clínico principal, melhora na escala de incapacidade de sete pontos, após o tratamento com uma das alternativas escolhida, a mediana dos pacientes que internaram com grau de gravidade 3 e que foram tratados com PE foi igual a dos que receberam IgIV. Em relação à permanência hospitalar, permanência em UTI e dias de Ventilação Mecânica, não houve diferença estatisticamente significativa entre os dois tratamentos. Conclusões: Quando comparados os custos médios das duas opções terapêuticas, uma delas aparece claramente com menor custo. Quando comparados os desfechos, após o emprego de cada opção terapêutica, estes não revelam diferença. Concluímos que, no HCPA, a opção pelo procedimento Plasmaferese é mais custo efetiva do que o emprego da IgIV. / Objectives: To compare the cost-effectiveness of two distinct therapies, Intravenous Immunoglobulin (IVIg) and Plasma Exchange (PE) in the treatment of Guillain-Barré Syndrome, concerning the public health care system. Compliance to the guidelines of the Pharmacy and Therapeutics Committee of the Hospital de Clínicas de Porto Alegre was a secondary objective. Methods: A cross-sectional, economical analysis was conducted, including patients treated for GBS in the period from June, 2003 through June, 2008 in Hospital de Clínicas de Porto Alegre (HCPA). The cost-effectiveness of the use of IVIg and PE in such patients was studied through the cost minimization method, considering direct medical costs only (2008 currency), yield by the management of the institution. Patients receiving treatments other than PE or IVIg were excluded. Data were collected by chart reviews. Severity of disease on admittance was classified as follows: mild disease, when the patient was able to walk; moderate disease, when the patient was unable to walk, and severe disease, when assisted ventilation was required. Disability on discharge was established by the 7-point scale of Hughes. Compliance to the guidelines of the Pharmacy and Therapeutics Committee was evaluated through the dose and prescription scheme of IVIg. Results: Twenty-five participants (2 to 70 years of age) were included in the study, 5 were submitted to treatment with PE, using human albumin as replacement for plasma, and 20 were treated with IVIg. The total treatment cost for PE in a single patient was US$6,058.85 (±1,701.78 SD), and the same expense for IVIg was US$18,344.57 (± 12,259.56 SD) (p = 0.035). Total inpatient cost was US$25,729.79 (± 18,714.54 SD) in the PE group, and US$34,768.16 (±27,766.01 SD) (p=0.530) in the IVIg group. The main clinical outcome was improvement in the 7-point disability grade scale. The median of that measure in patients admitted with a severity grade 3 treated either with PE and IVIg was the same. Secondary outcomes, such as in-hospital stay, ICU stay, and number of days on mechanical ventilation revealed no statistically significant difference between treatments. Conclusions: As the mean expenses of both therapeutic options are compared, one clearly stands-out as less onerous. Clinical outcomes, when compared, reveal no statistical difference after each treatment. We concluded that, in HCPA, plasma exchange is more cost-effective than intravenous immunoglobulin.

A efetividade do provimento jurisdicional é a mais importante das atividades da jurisdição. A simples declaração de um direito não é suficiente, se não for possível usufrui-lo. No caso de ações coletivas, a efetividade é a resposta para a pacificação de conflitos sociais de grandes dimensões. Todavia a efetividade de uma demanda coletiva é um dos maiores desafios tanto do Poder Judiciário como dos legitimados à ação coletiva, em vista das dificuldades que se apresentam na legislação, ensejando interpretações divergentes e que, por vezes, provocam o detrimento da tutela coletiva. O presente trabalho, a partir de dados empíricos sobre a experiência de uma espécie de legitimado à ação coletiva associação civil e mediante pesquisa estruturada da jurisprudência que se forma sobre o assunto, pretende levantar pontos sensíveis para a baixa efetividade dos provimentos jurisdicionais proferidos em ações coletivas. Os pontos sensíveis enfatizados são objeto de discussão e teorização, com o objetivo de apresentar caminhos e pontuar profundas dificuldades para a efetividade da tutela coletiva, sem a pretensão de dar solução para tais problemas, mas a ideia de alguns encaminhamentos, buscando a experiência no Direito Comparado. Conclui-se, essencialmente, que o caminho para a efetividade da demanda coletiva passa pela execução coletiva e pela tutela mandamental, que precisam ser melhor trabalhadas pelos legitimados e melhor apreciadas e compreendidas pelo Poder Judiciário. / The effectiveness of the jurisdictional provision is the most important activity of jurisdiction. The simple declaration of a right is not enough, if you can not enjoy it. In the case of class actions, the effectiveness is the answer to the pacification of large range social conflicts. Nonetheless, the effectiveness of a class action is a major challenge both the judiciary as the public and private entities those can file a class action, in view of the difficulties that arise in the legislation, allowing for different interpretations and that, sometimes, cause the detriment of collective defense. This paper, based on empirical data on the experience of a kind of private entity that can file a class action non-governmental organization and through structured research that establishes the cases on the subject, aims to raise sensitive issues for the low effectiveness of courts judgments in class action. Tender points emphasized are the subject of discussion and theorizing, with the goal of presenting paths and deep trouble for the effectiveness of collective defense, without claiming to provide solutions to such problems, but the idea of some referrals, seeking experience in Comparative Law. It is concluded, essentially, that the path to the effectiveness of collective class action goes through the collective enforcement by supervisory writ, that need to be worked by public and private entities those can file a class action and better appreciated and understood by the judiciary.

Made available in DSpace on 2016-03-15T19:34:17Z (GMT). No. of bitstreams: 1 Marina Domingues de Castro Camargo Aranha.pdf: 592650 bytes, checksum: 10a2ec1afd92339db80689da7fe66c5f (MD5) Previous issue date: 2015-02-10 / Universidade Presbiteriana Mackenzie / In view of the asymmetry of the labor relationships, as well as the powers granted to the employer, we notice that in several occasions the employer s decisions are as imperative as those emanated from the State, what makes the study of horizontal effectiveness of fundamental rights especially relevant in this area. Another important point to be aware is that the labor legislation does not provide specific provisions regarding the employee s right to privacy protection, reason why the general constitutional provisions are applicable to the labor relationships, given that, as a fundamental right, the right to privacy is inalienable and held by all the members of the society. Moreover, we find that the right to property is also constitutionally granted as a fundamental right and must be protected by the State as an employer right, even in the labor jurisdiction. Given to this conflict, we will reflect about the variables involving this concept and theories involving the effectiveness of fundamental rights and about its applicability, mostly in the relations between individuals. In addition, we will seek to the concept of the right of privacy opposed to the employer s right to property. Then, we will draw an overview of the employer s powers, scrutinizing its facets and boundaries to establish its extent considering the right to privacy in the workplace. Also, we will analyze the labor court s understandings subsequent to the publication of the 1988 Federal Constitution. / À vista da assimetria existente nas relações de trabalho, bem como pelos poderes conferidos ao empregador, observamos em diversas oportunidades decisões e manifestações tão imperativas quanto aquelas provindas do Estado, o que torna o estudo da eficácia horizontal dos direitos fundamentais especialmente relevante nesta seara. Outro ponto importante a se atentar é que a legislação trabalhista não contempla preceitos específicos referentes à proteção do direito à intimidade dos trabalhadores, aplicando-se nesta esfera as regras constitucionais gerais sobre o tema, sendo certo que, como um direito fundamental, é irrenunciável e de fruição geral. Verificamos, ainda, que o direito à propriedade também é constitucionalmente assegurado como direito fundamental e, consequentemente, deve ser tutelado pelo Estado, inclusive na seara trabalhista, como um direito do empregador. Diante deste conflito, no presente trabalho vamos refletir sobre as variáveis envolvidas no conceito de eficácia dos direitos fundamentais e teorias existentes acerca de sua aplicabilidade, notadamente nas relações interparticulares. Buscaremos, além disso, o conceito de direito à intimidade do empregado em contraponto com o direito à propriedade do empregador. Em seguida, traçaremos um panorama sobre os poderes do empregador, esmiuçando suas facetas e limites, para estabelecer a extensão e fruição do direito à intimidade no ambiente de trabalho, pormenorizando, ainda, entendimentos jurisprudenciais emblemáticos sobre o tema posteriores à Constituição de 1988.

A efetividade do provimento jurisdicional é a mais importante das atividades da jurisdição. A simples declaração de um direito não é suficiente, se não for possível usufrui-lo. No caso de ações coletivas, a efetividade é a resposta para a pacificação de conflitos sociais de grandes dimensões. Todavia a efetividade de uma demanda coletiva é um dos maiores desafios tanto do Poder Judiciário como dos legitimados à ação coletiva, em vista das dificuldades que se apresentam na legislação, ensejando interpretações divergentes e que, por vezes, provocam o detrimento da tutela coletiva. O presente trabalho, a partir de dados empíricos sobre a experiência de uma espécie de legitimado à ação coletiva associação civil e mediante pesquisa estruturada da jurisprudência que se forma sobre o assunto, pretende levantar pontos sensíveis para a baixa efetividade dos provimentos jurisdicionais proferidos em ações coletivas. Os pontos sensíveis enfatizados são objeto de discussão e teorização, com o objetivo de apresentar caminhos e pontuar profundas dificuldades para a efetividade da tutela coletiva, sem a pretensão de dar solução para tais problemas, mas a ideia de alguns encaminhamentos, buscando a experiência no Direito Comparado. Conclui-se, essencialmente, que o caminho para a efetividade da demanda coletiva passa pela execução coletiva e pela tutela mandamental, que precisam ser melhor trabalhadas pelos legitimados e melhor apreciadas e compreendidas pelo Poder Judiciário. / The effectiveness of the jurisdictional provision is the most important activity of jurisdiction. The simple declaration of a right is not enough, if you can not enjoy it. In the case of class actions, the effectiveness is the answer to the pacification of large range social conflicts. Nonetheless, the effectiveness of a class action is a major challenge both the judiciary as the public and private entities those can file a class action, in view of the difficulties that arise in the legislation, allowing for different interpretations and that, sometimes, cause the detriment of collective defense. This paper, based on empirical data on the experience of a kind of private entity that can file a class action non-governmental organization and through structured research that establishes the cases on the subject, aims to raise sensitive issues for the low effectiveness of courts judgments in class action. Tender points emphasized are the subject of discussion and theorizing, with the goal of presenting paths and deep trouble for the effectiveness of collective defense, without claiming to provide solutions to such problems, but the idea of some referrals, seeking experience in Comparative Law. It is concluded, essentially, that the path to the effectiveness of collective class action goes through the collective enforcement by supervisory writ, that need to be worked by public and private entities those can file a class action and better appreciated and understood by the judiciary.